Another example is bevacizumab, which inhibits vascular endothelial growth factor (VEGF) to suppress tumor angiogenesis and reduce tumor growth and metastasis, while enhancing the effectiveness of other treatments [97]. The gene discussed is VEGFA; the disease is neoplasm.